Sutter Davis Hospital
- Type
- Teaching hospital
- Where
- Davis, CA
- Medicare CCN
- 050537
- Received
- $65,815 in 26 records, 2023 ($4,288 general, $61,526 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 4 | $4,288 |
| 2023 | Research payment | 22 | $61,526 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Genentech, Inc. | 12 | $32,442 | 2023 |
| Boston Scientific Corporation | 5 | $13,367 | 2023 |
| Shockwave Medical, Inc | 1 | $11,745 | 2023 |
| Ethicon Endo-Surgery Inc. | 3 | $2,365 | 2023 |
| Medline Industries LP | 2 | $2,218 | 2023 |
| Stryker Corporation | 1 | $2,055 | 2023 |
| AstraZeneca UK Limited | 1 | $1,606 | 2023 |
| Bio-Rad Laboratories, Inc. | 1 | $14 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 22 | $61,526 |
| Debt forgiveness | 4 | $4,288 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | Stryker Corporation | $2,055 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-12-31 | Medline Industries LP | $2,034 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-12-31 | Medline Industries LP | $183 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-11-13 | Genentech, Inc. | $1,142 | Research payment | Cash or cash equivalent | Herceptin Biological, BioOncology | Chemo trastuzumab vs chemo trastuzumab pertuzumab | 2023 |
| 2023-09-29 | Genentech, Inc. | $966 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
| 2023-09-22 | Bio-Rad Laboratories, Inc. | $14 | Debt forgiveness | Cash or cash equivalent | Chemistry Device, Chemistry | 2023 | |
| 2023-09-11 | Boston Scientific Corporation | $214 | Research payment | Cash or cash equivalent | Clinical Trial Product Device, Clinical Trial Product PI | ELEGANCE | 2023 |
| 2023-08-01 | AstraZeneca UK Limited | $1,606 | Research payment | Cash or cash equivalent | IMFINZI Biological, Oncology | A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination | 2023 |
| 2023-07-17 | Boston Scientific Corporation | $115 | Research payment | Cash or cash equivalent | Clinical Trial Product Device, Clinical Trial Product PI | ELEGANCE | 2023 |
| 2023-07-03 | Ethicon Endo-Surgery Inc. | $1,207 | Research payment | Cash or cash equivalent | Neuwave Device, Ablation System | A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue | 2023 |
| 2023-05-29 | Ethicon Endo-Surgery Inc. | $579 | Research payment | Cash or cash equivalent | Neuwave Device, Ablation System | A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue | 2023 |
| 2023-05-22 | Boston Scientific Corporation | $12,000 | Research payment | Cash or cash equivalent | Clinical Trial Product Device, Clinical Trial Product ENDO | POCS IN PSC | 2023 |
| 2023-04-10 | Ethicon Endo-Surgery Inc. | $579 | Research payment | Cash or cash equivalent | Neuwave Device, Ablation System | A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue | 2023 |
| 2023-03-30 | Genentech, Inc. | $1,142 | Research payment | Cash or cash equivalent | Herceptin Biological, BioOncology | Chemo trastuzumab vs chemo trastuzumab pertuzumab | 2023 |
| 2023-02-27 | Boston Scientific Corporation | $601 | Research payment | Cash or cash equivalent | Clinical Trial Product Device, Clinical Trial Product PI | ELEGANCE | 2023 |
| 2023-02-14 | Shockwave Medical, Inc | $11,745 | Research payment | Cash or cash equivalent | Device | 2023 | |
| 2023-02-14 | Genentech, Inc. | $500 | Research payment | Cash or cash equivalent | Herceptin Biological, BioOncology | Chemo trastuzumab vs chemo trastuzumab pertuzumab | 2023 |
| 2023-02-10 | Genentech, Inc. | $1,000 | Research payment | Cash or cash equivalent | PostGraduate Roll Over Study | 2023 | |
| 2023-01-25 | Genentech, Inc. | $8,358 | Research payment | Cash or cash equivalent | PostGraduate Roll Over Study | 2023 | |
| 2023-01-25 | Genentech, Inc. | $500 | Research payment | Cash or cash equivalent | PostGraduate Roll Over Study | 2023 | |
| 2023-01-17 | Boston Scientific Corporation | $437 | Research payment | Cash or cash equivalent | Clinical Trial Product Device, Clinical Trial Product PI | ELEGANCE | 2023 |
| 2023-01-11 | Genentech, Inc. | $8,379 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
| 2023-01-11 | Genentech, Inc. | $4,130 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
| 2023-01-11 | Genentech, Inc. | $3,023 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
| 2023-01-11 | Genentech, Inc. | $1,800 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
| 2023-01-11 | Genentech, Inc. | $1,500 | Research payment | Cash or cash equivalent | TNKase Biological, Metabolism & Primary Care | Tenecteplase in stroke patients between 4 5 and 24 hours | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Davis, CA, county Yolo County, CA, state California; placed by its city name.
| Measure | Place (city or town) Davis, CA | County Yolo County, CA | State California |
|---|---|---|---|
| Population B01003 | 66,978 | 220,564 | 39,287,377 |
| Population, 2020 census P1 | 66,850 | 216,403 | 39,538,223 |
| Median age B01002 | 26.4 | 32.1 | 37.9 |
| Under 18 B01001 | 13.5% | 20.1% | 22.0% |
| 65 and over B01001 | 14.0% | 13.5% | 15.7% |
| Households B11001 | 25,358 | 76,693 | 13,548,091 |
| Foreign born B05002 | 19.0% | 21.0% | 27.0% |
| Median household income B19013 | $90,045 | $91,752 | $99,122 |
| Median family income B19113 | $169,957 | $122,185 | $113,346 |
| Per capita income B19301 | $51,329 | $43,733 | $49,513 |
| Poverty rate B17001 | 26.5% | 16.7% | 12.0% |
| Unemployment rate B23025 | 6.3% | 6.1% | 6.6% |
| Civilian labor force B23025 | 35,370 | 111,266 | 20,068,466 |
| Mean commute (minutes) B08013 | 22.3 | 24.0 | 28.7 |
| Bachelor's degree or higher B15003 | 76.8% | 44.8% | 37.1% |
| Housing units B25001 | 27,484 | 82,447 | 14,644,735 |
| Owner-occupied B25003 | 43.5% | 54.3% | 55.9% |
| Renters B25003 | 56.5% | 45.7% | 44.1% |
| Median home value B25077 | $866,100 | $620,700 | $734,700 |
| Median gross rent B25064 | $2,187 | $1,857 | $2,036 |
| White, not Hispanic B03002 | 49.9% | 41.8% | 33.8% |
| Black B03002 | 2.2% | 2.4% | 5.2% |
| Hispanic or Latino B03002 | 15.1% | 33.4% | 40.2% |
| Asian B03002 | 24.2% | 14.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.4% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Davis, CA.
Comments